One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Product Name:
Pea Protein(Isolated/Concentrated)
Specification:
Isolated 80%; Concentrated70%
Appearance:
Creamy yellow or yellow powder
Package:
20kg/bag
Products Description:
The product is made from the high-quality non-GMO peas exported from Canada and the USA. The working procedures include separating, homogenizing, sterilizing and spray drying. It’s yellow and fragrant with strong pea taste and has over 75% protein and 18 amino acids & vitamins without cholesterol. It has good gelatinization and water-solubility including dispersibility, stability and dissolution.
Application Range:
It can be used in vegetable protein beverages (peanut milk, wheat milk and walnut milk, etc.), health food & beverages and sausages based on its good water-solubility. It can also be used to increase protein content and stabilize quality in the milk powder processing (infant & student formula milk powder and milk powder for the middle-aged and senior) field.
Product Indexes:
Sensory Index
Physicochemical Index
Microbial Index
Color: creamy yellow or yellow
Protein≥75%
Total bacterial count≤20,000cfu/g
State: dry and loose powder
Ash content≤8%
Coli group≤70MPN/100g
Smell: it’s own flavor without peculiar smell
Moisture≤10%
Without pathogenic bacteria
Fineness (100-mesh passing rate)≥99%
PH 6-8
Packaging:
20kg/bag, paper & plastic compound bag, bag lined with kraft paper and PE food inner bag. It can also be packaged according to customer demands.
One year of qualification
Audited Supplier
Pharma Sources Insight January 2025
